Neurodevelopmental profile of siblings with Angelman syndrome due to pathogenic UBE3A variants

J Intellect Disabil Res. 2020 Mar;64(3):246-250. doi: 10.1111/jir.12700. Epub 2019 Dec 19.

Abstract

Background: Angelman syndrome (AS) is a neurodevelopmental disorder caused by a lack of expression of the maternally inherited UBE3A gene on chromosome 15. Individuals with AS due to a UBE3A mutation are more likely to have siblings who also have AS compared with those with AS due to other cytogenetic/molecular mechanisms, but it is unknown whether the developmental outcome of siblings who have AS is similar.

Methods: Through an ongoing AS Natural History Study, we identified seven pairs of siblings with AS due to a UBE3A mutation. We compared the neurodevelopment of the first-born and second-born siblings with AS participants who have a UBE3A mutation and have either typically developing siblings or no siblings.

Results: Second-born AS participants due to a UBE3A mutation were more likely to be diagnosed at an earlier age. With the exception of higher expressive language scores among the second-born participants, no other differences were observed in the developmental and adaptive functioning skills across the different groups.

Conclusions: The presence of an older sibling with the same neurodevelopmental disorder is associated with an earlier age of diagnosis and may be associated with an improvement in expressive language skills; the developmental outcome of siblings with AS due to a UBE3A mutation is otherwise comparable.

Keywords: UBE3A mutation; child development; developmental disability; phenotype; sibship.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Age Factors
  • Angelman Syndrome / diagnosis*
  • Angelman Syndrome / genetics
  • Angelman Syndrome / physiopathology*
  • Birth Order*
  • Child
  • Child, Preschool
  • Early Diagnosis
  • Female
  • Humans
  • Infant
  • Male
  • Siblings*
  • Ubiquitin-Protein Ligases / genetics*

Substances

  • UBE3A protein, human
  • Ubiquitin-Protein Ligases